|
Persistent Identifier
|
perma:LIST.KZVASI |
|
Publication Date
|
2026-07-06 |
|
Title
| Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe [* Cross-Reference *] |
|
Other Identifier
| https://doi.org/10.1016/j.jcyt.2025.09.007
OpenAlex ID: https://openalex.org/W4414480035 |
|
Author
| Delphine Ammar (Astellas Pharma (Netherlands))
Carmen Sanges (Universitäts-Kinderklinik Würzburg) - ORCID: https://orcid.org/0009-0000-1184-387X
David Henderson (Bayer (Germany)) - ORCID: https://orcid.org/0000-0002-6433-200X
Inga Schapitz (Bayer (Germany))
Michael Hudecek (Universitätsklinikum Würzburg)
Maik Luu (Universitätsklinikum Würzburg) - ORCID: https://orcid.org/0000-0003-2843-3919
Martina Schüßler‐Lenz (Paul Ehrlich Institut)
Christian J. Buchholz (Paul Ehrlich Institut) - ORCID: https://orcid.org/0000-0002-9837-7345
Paul Franz (Fraunhofer Institute for Cell Therapy and Immunology)
Kristin Reiche (Fraunhofer Institute for Cell Therapy and Immunology) - ORCID: https://orcid.org/0000-0002-4452-4872
Ulrike Koehl (Medizinische Hochschule Hannover) - ORCID: https://orcid.org/0000-0002-8159-9160
Norbert Ifrah (Institut National du Cancer) - ORCID: https://orcid.org/0000-0003-3063-850X
Bruno Quesnel (Institut National du Cancer) - ORCID: https://orcid.org/0000-0002-6563-2709
Maria Thermeli (Lymphoma Study Association)
Marie José Kersten (Lymphoma Study Association) - ORCID: https://orcid.org/0000-0002-8904-3802
Franco Locatelli (Bambino Gesù Children's Hospital) - ORCID: https://orcid.org/0000-0002-7976-3654
Maria Luisa D'Amore (Bambino Gesù Children's Hospital) - ORCID: https://orcid.org/0000-0003-3488-4695
Chiara Bonini (Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele) - ORCID: https://orcid.org/0000-0002-0772-1674
Monica Casucci (Vita-Salute San Raffaele University, Istituti di Ricovero e Cura a Carattere Scientifico, Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele) - ORCID: https://orcid.org/0000-0003-4500-9060
Ulrike Philippar (European Hematology Association)
Robin Doeswijk (European Hematology Association)
Frederick W. Thielen (Erasmus University Rotterdam) - ORCID: https://orcid.org/0000-0002-0312-5891
Carin Uyl-de Groot (Erasmus University Rotterdam)
Judith Theelen (Miltenyi Biotec (Germany))
Bernd Schröder (Miltenyi Biotec (Germany)) - ORCID: https://orcid.org/0000-0003-0774-6270
Andreas Kremer (Luxembourg Institute of Science and Technology, Arbed (Luxembourg)) - ORCID: https://orcid.org/0000-0003-1466-0600
Maria Quaranta (Luxembourg Institute of Science and Technology, Arbed (Luxembourg)) - ORCID: https://orcid.org/0000-0001-7424-0240
Felipe Prósper (Clinica Universidad de Navarra) - ORCID: https://orcid.org/0000-0001-6115-8790
Jan Brülle (University of Würzburg) - ORCID: https://orcid.org/0000-0002-7102-5649
Ulf Grawunder (University of Würzburg)
Emmanuel Donnadieu (Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Institut Cochin) - ORCID: https://orcid.org/0000-0002-4985-7254
Anne Galy (Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Institut Cochin) - ORCID: https://orcid.org/0000-0002-0153-4392
Christophe Ferrand (Centre National de la Recherche Scientifique, Inserm, Université Paris Cité, Institut Cochin) - ORCID: https://orcid.org/0000-0003-0119-3919
Nina Worel (University of Würzburg) - ORCID: https://orcid.org/0000-0002-3599-8099
Dirk H. Busch (Institute of Medical Microbiology and Hygiene, Technical University of Munich) - ORCID: https://orcid.org/0000-0001-8713-093X
Javier Briones (Hospital de Sant Pau) - ORCID: https://orcid.org/0000-0003-2750-3735
Leopold Sellner (Takeda (Germany), Takeda (Japan)) - ORCID: https://orcid.org/0000-0002-7893-401X
Jürgen Kuball (University Medical Center Utrecht) - ORCID: https://orcid.org/0000-0002-3914-7806
Anna Sureda (Institut Català d'Oncologia) - ORCID: https://orcid.org/0000-0002-1238-6970
Jacquelyn Awigena-Cook (Bristol-Myers Squibb (Germany), Bristol-Myers Squibb (United Kingdom), Bristol-Myers Squibb (Italy)) - ORCID: https://orcid.org/0000-0001-8521-0944 |
|
Point of Contact
|
Use email button above to contact.
LIST QDKM (LIST) |
|
Description
| With the proposal for major reform of the pharmaceutical legislation (Regulation (EU) 2023/0131, Directive (EU) 2023/0132) in April 2023, the foundations of Europe's regulatory architecture are being reshaped. The revised legislation proposes the removal of specialized committee functions (e.g., Committee for Advanced Therapies—CAT) by integrating their remit into other regulatory bodies, such as the Pharmacovigilance Risk Assessment Committee (PRAC) and Committee for Medicinal Products for Human Use (CHMP) and expert working groups. This decision may further challenge innovation in Europe, particularly in the field of advanced therapy medicinal products (ATMPs), which has already experienced a notable decline in global clinical trial activity over the past decade. This article emphasizes the importance of involving multistakeholder consortia such as T2EVOLVE in shaping pharmaceutical legislation to prevent the loss of specialized knowledge and the need for robust mechanisms that preserve developers’ access to ATMP regulatory expertise. (2025-09-24)
***This entry has been automatically imported via OpenAlex by LIST harvest scripts. Please refer to https://doi.org/10.1016/j.jcyt.2025.09.007 for the original and latest version of the publication*** (2026-07-01) |
|
Subject
| Business and Management; Medicine, Health and Life Sciences; Social Sciences |
|
Keyword
| Legislation
Directive
Regulatory affairs
Regulatory authority
Pharmacovigilance
Steering committee |
|
Topic Classification
| Biomedical Ethics and Regulation
Biotechnology and Related Fields
Health Systems, Economic Evaluations, Quality of Life |
|
Deposit Date
| 2025-09-24 |
|
Data Type
| Article |
|
Data Source
| Cytotherapy |